Characteristics of deslanoside-induced modulation on jejunal contractility

World Journal of Gastroenterology

Volumn 18, Issue 41, 2012, Pages 5889-5896

  Chen, Da Peng ^a   Xiong, Yong Jian ^a   Tang, Ze Yao ^a   Yao, Qi Ying ^a   Ye, Dong Mei ^a   Liu, Sha Sha ^a   Lin, Yuan ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Bidirectional regulation; Contractile state; Deslanoside; Jejunal smooth muscle

Indexed keywords

ATROPINE; BUFFER; CALCIUM ION; CIMETIDINE; DESLANOSIDE; DIPHENHYDRAMINE; MYOSIN LIGHT CHAIN; PHENTOLAMINE; POTASSIUM ION; PROPRANOLOL; SODIUM ION; TETRODOTOXIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; EX VIVO STUDY; JEJUNUM; MUSCLE CONTRACTILITY; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

EID: 84873892811     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i41.5889     Document Type: Article

References (36)

1. Froberg B, Ibrahim D, Furbee RB. Plant poisoning. Emerg Med Clin North Am 2007; 25: 375-433; abstract ix
2. Mijatovic T, Van Quaquebeke E, Delest B, Debeir O, Darro F, Kiss R. Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys Acta 2007; 1776: 32-57
3. Prassas I, Diamandis EP. Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov 2008; 7: 926-935
4. Winnicka K, Bielawski K, Bielawska A. Cardiac glycosides in cancer research and cancer therapy. Acta Pol Pharm 2006; 63: 109-115
5. Yang P, Menter DG, Cartwright C, Chan D, Dixon S, Suraokar M, Mendoza G, Llansa N, Newman RA. Oleandrinmediated inhibition of human tumor cell proliferation: importance of Na, K-ATPase alpha subunits as drug targets. Mol Cancer Ther 2009; 8: 2319-2328
6. Arispe N, Diaz JC, Simakova O, Pollard HB. Heart failure drug digitoxin induces calcium uptake into cells by forming transmembrane calcium channels. Proc Natl Acad Sci USA 2008; 105: 2610-2615
7. Liu J, Tian J, Haas M, Shapiro JI, Askari A, Xie Z. Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem 2000; 275: 27838-27844
8. Saunders R, Scheiner-Bobis G. Ouabain stimulates endothelin release and expression in human endothelial cells without inhibiting the sodium pump. Eur J Biochem 2004; 271: 1054-1062
9. Barajas-López C, Huizinga JD. Ouabain-induced excitation of colonic smooth muscle due to block of K+ conductance by intracellular Na+ ions. Eur J Pharmacol 1992; 221: 51-58
10. Hansen MB. Neurohumoral control of gastrointestinal motility. Physiol Res 2003; 52: 1-30
11. Schemann M. Control of gastrointestinal motility by the "gut brain"--the enteric nervous system. J Pediatr Gastroenterol Nutr 2005; 41 Suppl 1: S4-S6
12. Pimentel M. The Treatment of Patients With Irritable Bowel Syndrome: Review of the Latest Data From the 2010 DDW Meeting. Gastroenterol Hepatol (N Y) 2010; 6: 1-15
13. Ringel Y, Sperber AD, Drossman DA. Irritable bowel syndrome. Annu Rev Med 2001; 52: 319-338
14. Tack J, Fried M, Houghton LA, Spicak J, Fisher G. Systematic review: the efficacy of treatments for irritable bowel syndrome--a European perspective. Aliment Pharmacol Ther 2006; 24: 183-205
15. Zou BC, Dong L, Wang Y, Wang SH, Cao MB. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome. Chin Med J (Engl) 2007; 120: 2069-2074
16. Peng LH, Yang YS, Sun G, Wang WF. A new model of Constipation-predominant irritable bowel syndrome in rats. Shijie Huaren Xiaohua Zazhi 2004; 12: 112-116
17. La JH, Kim TW, Sung TS, Kang JW, Kim HJ, Yang IS. Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J Gastroenterol 2003; 9: 2791-2795
18. Mozaffari S, Esmaily H, Rahimi R, Baeeri M, Sanei Y, Asadi-Shahmirzadi A, Salehi-Surmaghi MH, Abdollahi M. Effects of Hypericum perforatum extract on rat irritable bowel syndrome. Pharmacogn Mag 2011; 7: 213-223
19. La JH, Kim TW, Sung TS, Kim HJ, Kim JY, Yang IS. Increase in neurokinin-1 receptor-mediated colonic motor response in a rat model of irritable bowel syndrome. World J Gastroenterol 2005; 11: 237-241
20. Mathison R, Shaffer E. Increased cholinergic contractions of jejunal smooth muscle caused by a high cholesterol diet are prevented by the 5-HT4 agonist--tegaserod. BMC Gastroenterol 2006; 6: 8
21. Zhu J, Chen L, Xia H, Luo HS. Mechanisms mediating CCK-8S-induced contraction of proximal colon in guinea pigs. World J Gastroenterol 2010; 16: 1076-1085
22. Frings M, Haschke G, Heinke B, Schäfer KH, Diener M. Spontaneous contractions of intestinal smooth muscle reaggregates from the new-born rat triggered by thromboxane A2. J Vet Med A Physiol Pathol Clin Med 2000; 47: 469-475
23. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ, Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 1997; 49: 157-230
24. Scarpignato C, Pelosini I. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility. Can J Gastroenterol 1999; 13 Suppl A: 50A-65A
25. Chen D, Xiong Y, Wang L, Lv B, Lin Y. Characteristics of emodin on modulating the contractility of jejunal smooth muscle. Can J Physiol Pharmacol 2012; 90: 455-462
26. Kobayashi K, Murata T, Hori M, Ozaki H. Prostaglandin E2-prostanoid EP3 signal induces vascular contraction via nPKC and ROCK activation in rat mesenteric artery. Eur J Pharmacol 2011; 660: 375-380
27. Iwabu A, Smith K, Allen FD, Lauffenburger DA, Wells A. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway. J Biol Chem 2004; 279: 14551-14560
28. Quigley EM. Prebiotics for irritable bowel syndrome. Expert Rev Gastroenterol Hepatol 2009; 3: 487-492
29. Galligan JJ. Enteric P2X receptors as potential targets for drug treatment of the irritable bowel syndrome. Br J Pharmacol 2004; 141: 1294-1302
30. Chang FY, Lu CL. Treatment of irritable bowel syndrome using complementary and alternative medicine. J Chin Med Assoc 2009; 72: 294-300
31. Dunphy RC, Verne GN. Drug treatment options for irritable bowel syndrome: managing for success. Drugs Aging 2001; 18: 201-211
32. Kraneveld AD, Rijnierse A, Nijkamp FP, Garssen J. Neuroimmune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets. Eur J Pharmacol 2008; 585: 361-374
33. Mang CF, Truempler S, Erbelding D, Kilbinger H. Modulation by NO of acetylcholine release in the ileum of wild-type and NOS gene knockout mice. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1132-G1138
34. Li M, Johnson CP, Adams MB, Sarna SK. Cholinergic and nitrergic regulation of in vivo giant migrating contractions in rat colon. Am J Physiol Gastrointest Liver Physiol 2002; 283: G544-G552
35. Lu CL, Chen CY, Chang FY, Lee SD. Characteristics of small bowel motility in patients with irritable bowel syndrome and normal humans: an Oriental study. Clin Sci (Lond) 1998; 95: 165-169
36. Goldstein AM, Nagy N. A bird's eye view of enteric nervous system development: lessons from the avian embryo. Pediatr Res 2008; 64: 326-333